Quarry LP’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,727
Closed -$17.1K 2164
2025
Q2
$17.1K Buy
1,727
+559
+48% +$5.47K ﹤0.01% 1232
2025
Q1
$11K Buy
+1,168
New +$12.3K ﹤0.01% 1250
2024
Q4
Sell
-8,518
Closed -$66.3K 1615
2024
Q3
$66.3K Buy
8,518
+2,471
+41% +$17.8K 0.02% 590
2024
Q2
$36.6K Buy
6,047
+2,594
+75% +$16K 0.01% 819
2024
Q1
$20.3K Buy
3,453
+704
+26% +$4.18K ﹤0.01% 925
2023
Q4
$21.6K Buy
2,749
+1,472
+115% +$10.2K ﹤0.01% 710
2023
Q3
$9.34K Buy
+1,277
New +$10.6K ﹤0.01% 929
2023
Q2
Sell
-3,899
Closed -$40.3K 1048
2023
Q1
$40.3K Buy
3,899
+2,708
+227% +$34.7K 0.01% 337
2022
Q4
$16.4K Buy
+1,191
New +$16.6K ﹤0.01% 445

Other funds holding ANGO

Quarry LP's ANGO Position: Q3 2025 in Review

Quarry LP sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 1,727 shares — an estimated $17.1K sold.

Quarry LP first reported a position in ANGO in Q4 2022 and held it in 9 quarters. The position peaked at $66.3K in Q3 2024. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Quarry LP reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Quarry LP sold 1,727 AngioDynamics shares in Q3 2025, an estimated $17.1K.
  • Quarry LP first reported a position in AngioDynamics in Q4 2022 and held it in 9 quarters.
  • Quarry LP's AngioDynamics position peaked at $66.3K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.